...

Choroba afektywna dwubiegunowa z perspektywy neurochemicznej cz.2

Choroba afektywna dwubiegunowa (ChAD) wciąż stanowi wyzwanie dla lekarzy. W tym artykule opowiemy o wykorzystaniu soli litu w leczeniu ChAD.

Nie masz dostępu do tych treści

Wygląda na to, że nie masz rangi Czytelnik,
aby ją otrzymać zaloguj się klikając na przycisk poniżej.

Bibliografia
  1. BENARD, V., VAIVA, G., MASSON, M., GEOFFROY, P.A. 2016. Lithium and suicide prevention in bipolar disorder. Encéphale 42, 234-241.
  2. BLACK, G.C., CHEN, Z.Y., CRAIG, I.W., POWELL, J.F. 1991. Dinucleotide repeat polimorphism at the MAOA locus. Nucleid Acids Res. 19, 689.
  3. BRILEY, M.S., LANGER, S.Z., RAIMAN, R., SECHTER, D., ZARIFIAN, E. 1980. Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science 209, 303-305.
  4. CAN, A., SCHULZE, T.G., GOULD, T.D. 2014. Molecular actions and clinical pharmacogenetics of lithium therapy. Pharmacol. Biochem. Behav. 123, 3-16.
  5. CHEN, G., ZENG, W.Z., YUAN, P.X., HUANG, L.D., JLANG, Y.M. 1999. The mood stabilizing agents lithium and and valproate robustly increase the level of neuroprotective protein Bcl-2 in the CNS. J. Neurochem. 72, 879-882.
  6. CHUANG, D., CHEN, R., CHALECKA-FRANASZEK, E., REN, M. 2002. Neuroprotective effect of lithium in cultured cells and animal models of disease. Bipolar Disorders 4, 129-136.
  7. CORBELLA, B., VIETA, E. 2003. Molecular targets of lithium action. Acta Neuropsychiatrica 15, 316-340.
  8. CRADDOCK, N., DANIELS, J., ROBERTS, E., REES, M., MCGUFFIN, P., OWEN, M.J. 1995. No evidence for allelic association between bipolar disorder and monoamine oxidase A gene polymorphism. Am. J. Med. Genet. 60, 322-324.
  9. DE FRIAS, C.M., ANNERBRINK, K., WESTBERG, L. ET AL. 2004. COMT gene polymorphism is associated with declarative memory in adulthood and old age. Behav. Genet. 34, 533-539.
  10. DECKERT, J., CATALANO, M., SYAGAILO, Y., BOSI, M. ET AL. 1999. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum. Molec. Genet. 8, 621-624.
  11. DIXON, J.F., HOKIN, L.E. 1997. The antibipolar drug valproate mimic lithium in stimulating glutamate release IP3 accumulation in brain cortex slices but not accumulation of inositol monophosphates and biphosphates. Proc. Natl. Acad. Sci. USA 94, 4757-4760.
  12. DIXON, J.F., HOKIN, L.E. 1998. Lithium acutely inhibits and chronically up-regulates and and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proc. Natl. Acad. Sci. USA 95, 363-368.
  13. EGAN, M., GOLDBERG, T., KOLACHANA, B. ET AL. 2001. Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc. Nat. Acad. Sci. USA 98, 6917-6922.
  14. FALLON, S.J., WILLIAMS-GRAY, C.H., BARKER, R.A., OWEN, A.M., HAMPSHIRE, A. 2013. Prefrontal Dopamine Levels Determine the Balance between Cognitive Stability and Flexibility. Cereb. Cortex. 23, 361-369.
  15. FURLONG, R.A., HO, L., WALSH, C., RUBINSZTEJN, J.S., JAIN, S., PAYKEL, E.S. ET AL. 1998. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am. J. Med. Genet. 81, 58-63.
  16. GEOFFROY, P.A., ETAIN, B., SCOTT., J., HENRY, C., JAMAIN, S., LEBOYER, M., BELLIVIER, F. 2013. Reconsideration of bipolar disorder as a developmental disorder: Importance of the time of onset. J. Physiol. Paris 107, 278-285.
  17. GERSHON, S., CHENGAPPA, K.N.R., MALHI, G.S. 2009. Lithium specificity in bipolar illness: a classic agent for the classic disorder. Bipolar Disord. 11, 34-44.
  18. GHRIBI, O., HERMAN, M.M., SPAULDING, N.K., SAVORY, J. 2002. Lithium inhibits aluminium-induced apoptosis in rabbit hippocampus, by preventing cytochrome c translocation, Bcl-2 decrease, Bax elevation and caspase-3 activation. Journal of Neurochemistry 82, 137-145.
  19. GOLDBERG, T.E., EGAN, M.F., GSCHEIDLE, T. ET AL. 2003. Executive subprocesses in working memory: relationship to catechol-o-methyltransferase Val158Met genotype and schizophrenia. Arch. Gen. Psychiatry 60, 889-896.
  20. GRABOWSKI, Ł. 2020. Enzym katecholo-O-metylotransferaza (COMT) w zespołach psychotycznych. [W:] Poszerzamy Horyzonty Tom XXI Część III. M. BOGUSZ, A. PIOTROWSKA-PUCHAŁA, M. WOJCIESZAK (red.).Wydawnictwo Mateusz Weiland Network Solutions, Słupsk, 455-466.
  21. GRIMBSY, J., CHEN, K., WANG, L., LAN, N., SHIH, J. 1991. Human monoamine oxydase A and B genes exhibit identical exon-intron organization. Proc. Nat. Acad. Sc. USA 88, 3637- 3641.
  22. GRYGLEWSKI, R. 1982. Leki układu autonomicznego. [W:] Farmakologia. Podręcznik dla studentów medycyny. A. DANYSZ, R. GRYGLEWSKI (red.). Państwowy Zakład Wydawnictw Lekarskich, Warszawa, 146-238.
  23. HAUSER, J., LESZCZYŃSKA, A., SAMOCHOWIEC, J., OSTAPOWICZ, A. ET AL. 2002. The association study of the functional polymorphism of the MAO-A gene promoter in patients with affective disorders. Arch. Psychiatr.
  24. HINDS, H.L., HENDRIKS, R.W., CRAIG, I.W., CHEN, Z.Y. 1992. Characterization of a highly polymorphic region near the first exon of the human MAOA gene containing a GT dinucleotide and a novel VNTR motif. Genomics 13, 896-897.
  25. HONG, C.J., TSAI, S.J., CHENG, C.Y., LIAO, W.Y., SONG, H.L., LAI, H.C. 1999. Association analysis of the 5-HT(6) receptor polymorphism (C267T) in mood disorders. Am. J. Med. Genet. 88, 601-602.
  26. HOTAMISLIGIL, G.S., BREAKEFIELD, X.O. 1991. Human monoamine oxidase A gene determines levels of enzyme activity. Am. J. Hum. Genet. 49, 383-392.
  27. HUKIC, D.S., FRISEN, L., BACKLUND, L., LAVEBRATT, C., LANDEN, M., TRASKMAN-BENDZ, L., EDMAN, G., SCHALLING, M., OSBY, U. 2013. Cognitive Manic Symptoms in Bipolar Disorder Associated with Polymorphisms in the DAOA and COMT Genes. PLoS One 8, e67450.
  28. IKONOMOR, O.C., MANJI, H.K. 1999. Molecular mchanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge. Am. J. Psychiatry 156, 1506-1514.
    JIANG, S., XIN, R., LIN, S., QIAN, Y., TANG, G., WANG, D., WU, X. 2001. Linkage studies between attention-deficit hyperactivity disorder and the monoamine oxidase genes. Am. J. Med. Genet. 105, 783-788.
  29. KAMIŃSKI, K., MATUSZEWSKI, W. 1975. Różnorodne formy monoaminooksydazy. Post. Biochem. 21, 369-382.
  30. KARHUNEN, T., TILGMANN, C., ULMANEN, I., PANULA, P. 1995. Catechol-Omethyltransferase (COMT) in rat brain: immunoelectron microscopic study with an antiserum against rat recombinant COMT protein. Neurosci. Lett. 187, 57-60.
  31. KAROUM, F., CHRAPUSTA, S.J., EGAN, M.F. 1994. 3-Methoxytryramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J. Neurochem. 63, 972-979.
  32. KATO, T. 2001. Molecular genetics of bipolar disorder. Neuroscience Research 40, 105-113.
  33. KAWADA, Y., HATTORI, M., DAI, X.Y., NANKO, S. 1995. Possible association between monoamine oxidase A gene and bipolar affective disorder. Am. J. Hum. Genet. 56, 335-336.
  34. KOFMAN, O., BELMAKER, R.H. 1990. Intracerebroventricular myo-inositol antagonizes lithium – induced supression of rearing behaviour in rats. Brain Res. 534, 345-347.
  35. KONARDI, C., OZELIUS, L., BREAKFIELD, X. 1992. Highly polymorphic (GT)n repeat sequence in intron II of the human MAO-B gene. Genom. 12, 176-177.
  36. KOTLER, M., BARAK, P., COHEN, H., AVERBUCH, I.E., GRINSHPOON, A., GRITSENKO, I., NEMANOV, L., EBSTEIN, R.P. 1999. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol Omethyltransferase (COMT) activity. Am. J. Med. Genet. 88, 628-633.
  37. LACHMAN, H.M., PAPOLOS, D.F., SAITO, T., YU, Y.M., SZUMLANSKI, C.L., WEINSHILBOUM, R.M. 1996. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6, 243-250.
  38. LELLI-CHIESA, G., KEMPTON, M.J., JOGIA, J., TATARELLI, R., GIRARDI, P., POWELL, COLLIER, D.A., FRANGOU, S. 2011. The impact of the Val158Met catechol-Omethyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives. Psychol. Med. 41, 779-788.
  39. LESCH, K.P., MOSSNER, R. 1998. Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol. Psychiatry 44, 179-192.
  40. LICHT, R.W. 2012. Lithium: still a major option in the management of bipolar disorder. CNS Neuroscience & Therapeutics 18, 219-226.
  41. LIM, L.C., POWELL, J., SHAM, P., CASTLE, D., HUNT, N., MURRAY, R., GILL, M. 1995. Evidence for a genetic association between alleles of monoamine oxidase A gene and bipolar affective disorder. Am. J. Med. Genet. 60, 325-331.
  42. LIN, S., JIANG, S., WU, X., QUIAN, Y. ET AL. 2000. Association analysis between mood disorders and monoamine oxidase gene. Am. J. Med. Genet. 96, 12-14.
  43. LINDSAY, E., GOLDBERG, R., JURECIC, V. 1995. Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions. Am. J. Med. Genet. 57, 514-522.
  44. MANJI, H.K., MOORE, G.J., CHEN, G. 2000. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J. Clin. Psychiatry 61 (supl. 9), 82-96.
  45. MASANA, M.I., BRITRAN, J.A., HSIAO, J.K., POTTER, W.Z. 1992. In vivo evidence that lithium inactivates Gi modulation of adenylate cyclase in brain. J. Neurochem. 59, 200-205.
  46. MINASSIAN, A., YOUNG, J.W., GEYER, M.A., KELSOE, J.R., PERRY, W. 2017. The COMT Val158Met Polymorphism and Exploratory Behavior in Bipolar Mania. Mol. Neuropsychiatry 3, 151-156.
  47. MOTOHASHI, N. 1992. GABA receptors alternations after chronic lithium administration. Comparison with carbamazepine and sodium valproate. Prog. Neuropsychopharmacol. Biol. Psychiatry 16, 571-579.
  48. MUNDO, E., WALKER, M., TIMS, H., MACCIARDI, F., KENNEDY, J.L. 2000. Lack of linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and bipolar disorder. Am. J. Med. Genet. 96, 379-383.
  49. NOLAN, K.A., VOLAVKA, J., CZOBOR, P., CSEH, A., LACHMAN, H., SAITO, T., TIIHONEN, J., PUTKONEN, A. ET AL. 2000. Suicidal behavior in patients with schizophrenia is related to COMT polymorphism. Psychiatr. Genet. 10, 117-124.
  50. ORUC, L., VERHEYEN, G.R., FURAC, I., JAKOVLJEVIC, M., IVEZIC, S., RAEYMAEKERS, P., VAN BROECKHOVEN, C. 1997. Association analysis of the 5-HT2C receptor and 5-HT transporter genes in bipolar disorder. Am. J. Med. Genet. 74, 504-506.
  51. OWENS, M.J., NEMEROFF, C.B. 1994. Role of serotonin in pathophysiology of depression: focus on the serotonin transporter. Clin. Chem., 40, 288-295.
  52. PARSIAN, A., TODD, R.D. 1997. Genetic association between monoamine oxidase and manic-depressive illness: comparison of relative risk and haplotype relative risk data. Am. J. Med. Genet. 74, 475-479.
  53. PHILLIPS, M.L., SWARTZ, H.A. 2014. A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research. Am. J. Psychiatry 171, 829-843.
  54. PIETRUCZUK, K., WITKOWSKI, J.M. 2008. Mechanizmy działania soli litu. Psychiatria 5, 51-57.
  55. PIGONI, A., LAZZARETTI, M., MANDOLINI, G.M., DELVECCHIO, G., ALTAMURA, A.C., SOARES, J.C., BRAMBILLA, P. 2018. The impact of COMT polymorphisms on cognition in Bipolar Disorder: a review. Journal of Affective Disorders. doi: https://doi.org/10.1016/j.jad.2018.08.009
  56. POMPILI, M., GONDA, X., SERAFINI, G., INNAMORATI, M., SHER, L., AMORE, M., RIHMER, Z., GIRARDI, P. 2013. Epidemiology of suicide in bipolar disorders: a systematic review of the literature. Bipolar Disord. 15, 457-490. doi: https://doi.org/10.1111/bdi.12087
  57. POTASH, J.B., DEPAULO, J.R. 2000. Searching high and low: a review of the genetics of bipolar disorder. Bipolar Disord. 2, 8-26.
  58. PREISIG, M., BELLIVIER, F., FENTON, B.T., BAUD, P., BERNEY, A., COURTET, P. ET AL. 2000. Association Between Bipolar Disorder and Monoamine Oxidase A Gene Polymorphisms: Results of Multicenter Study. Am. J. Psychiatry, 157, 948-955.
  59. QUEDNOW, B.B., WAGNER, M., MOSSNER, R., MAIER, W., KUHN, K.U. 2010. Sensorimotor gating of schizophrenia patients depends on catechol O-methyltransferase Val158Met polymorphism. Schizophr. Bull. 36, 341-346.
  60. RUBINSZTEIN, D.C., LEGGO, J., GOODBURN, S., WALSH, C., JAIN, S., PAYKEL, E.S. 1996. Genetic association between monoamine oxidase A microsatellite and RFLP alleles and bipolar affective disorder: analysis and meta-analysis. Hum. Mol. Genet. 5, 779-782.
  61. SABOL, S., HU, S., HAMER, D. 1998. A functional polymorphism in the monoamine oxidase A gene promoter. Hum. Genet. 103, 273-279.
  62. SCOTT, N., READING, H., LOUNDON, J. 1979. Studies on human platelets in affective disorders. Psychopharmacology (Berl) 60, 131-135.
  63. SEEBERG, I., NIELSEN, I.B., JØRGENSEN, C.K., ESKESTAD, N.D., MISKOWIAK, K.W. 2021. Effects of psychological and pharmacological interventions on anxiety symptoms in patients with bipolar disorder in full or partial remission: A systematic review. Journal of Affective Disorders 279, 31-45.
  64. SHIMRON-ABARBANELL, D., HARMS, H., ERDMANN, J., ALBUS, M., MAIER, W., RIETSCHEL, M., KORNER, J., WEIGELT, B., FRANZEK, E. ET AL. 1996. Systematic screening for mutations in the human serotonin 1F receptor gene in patients with bipolar affective disorder and schizophrenia. Am. J. Med. Genet. 67, 225-228.
  65. SOEIRO DE SOUZA, M.G., BIO, D.S., DAVID, D.P., RODRIGUES DOS SANTOS, D., KERR, D.S., GATTAZ, W.F., MACHADO-VEIRA, R., MORENO, R.A. 2012a. COMT Met (158) modulates facial emotion recognition in bipolar I disorder mood episodes. J. Affect. Disord. 136, 370-376.
  66. PRADO, C.M., MORENO, R.A. 2012b. COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder. Bipolar Disord. 14, 554–64.
  67. TALAROWSKA, M., GAŁECKI, P. 2017. Teoria wczesnych nieadaptacyjnych schematów Younga z perspektywy teorii neurorozwojowej depresji. Neuropsychiatria i Neuropsychologia 12, 101-107.
  68. TYLEC, A., STRYJECKA-ZIMMER, M., KUCHARSKA-PIETURA, K. 2007. Polimorfizm genu MAO w zaburzeniach psychicznych. Psychiatria Polska 41, 485-493.
  69. VAN PRAAG, H.M., KORF, J., PUITE, J. 1970. 5-hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature 225, 1259-1260.
  70. VINCENT, J.B., MASELLIS, M., LAWRENCE, J., CHOI, V., GURLING, H.M., PARIKH, S.V., KENNEDY, J.L. 1999. Genetic association analysis of serotonin system genes in bipolar affective disorder. Am. J. Psychiatry 156, 136-138
  71. VOGT, I.R., SHIMRON-ABARBANELL, D., NEIDT, H., ERDMANN, J., CICHON, S., SCHULZE, T.G. ET AL. 2000. Investigation of the human serotonin 6 [5-HT6] receptor gene in bipolar affective disorder and schizophrenia. Am. J. Med. Genet. 96, 217-221.
  72. YEREVANIAN, B.I., CHOI, Y.M. 2013. Impact of psychotropic drugs on suicide and suicidal behaviors. Bipolar Disord. 15, 594-621.
  73. YOUNG, J.W., MINASSIAN, A., PAULUS, M.P., GEYER, M.A., PERRY, W. 2007. A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neurosci. Biobehav. Rev. 31, 882-896.
Udostępnij:
Facebook
Twitter
LinkedIn

Ostatnie wpisy:

Podziel się opinią!

polecane wpisy:

Dzieci powinny czytać

W młodym wieku zachodzą kluczowe procesy plastyczności neuronalnej, które są istotne dla rozwoju mózgu. Dlatego warto wspierać u dzieci zachowania kształtujące ich rozwój, ponieważ mogą okazać się korzystne w dorosłym życiu. Przykładem takiego zachowania jest czytanie książek, czyli jedna z...

Kondycja wątroby a funkcje poznawcze

Przewlekłe choroby wątroby są coraz to bardziej powszechne w społeczeństwie. W ich przebiegu obserwuje się postępujące zmiany polegające na stopniowym zastępowaniu prawidłowego miąższu wątroby tkanką włóknistą, co prowadzi do zaburzeń struktury i funkcji tego narządu. Coraz więcej doniesień naukowych wskazuje,...

Jak białka pomagają spać

Sen pojawił się na wczesnym etapie ewolucji zwierząt i pełni podobną funkcję u wielu gatunków. Zarówno jego długość, jak i jakość jest ważna dla zachowania zdrowia. Jakość snu określana jest m.in. na podstawie częstotliwości i ilości wybudzeń w ciągu nocy....

Archiwum: